• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » antipsychotics

Items Tagged with 'antipsychotics'

ARTICLES

RLS_shutterstock_742328920.jpg
Expert Q&A

Akathisia: Manifestations and Treatment

January 1, 2025
Michael Poyurovsky, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

A6E5C1A5-E6B5-4BB1-9138-E64ADEC5C6CA.pngMichael Poyurovsky, MD

Associate professor, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.

Dr. Poyurovsky has no financial relationships with companies related to this material.

Dr. Poyurovsky offers practical guidance for identifying and treating akathisia, a movement disorder marked by inner restlessness. He highlights the importance of psychoeducation, gradual dose adjustments, and the use of propranolol or low-dose mirtazapine for relief. He underscores the importance of distinguishing akathisia from other conditions, like psychotic agitation, to avoid unnecessary increases in antipsychotic doses.


Read More
Research Update

Strategies to Reduce Antipsychotic-Induced Hyperprolactinemia

January 1, 2025
Sarah Azarchi, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

Five strategies to reduce prolactin on antipsychotics tested in this meta-analysis


Read More
Research Update

Esketamine vs Quetiapine in ­Treatment-Resistant Depression

November 1, 2024
Ivy Song, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Ivy Song, MD. Dr. Song has no financial relationships with companies related to this material.

Esketamine outperforms quetiapine in TRD remission rates, but the clinical significance of this difference remains uncertain.


Read More
Research Update

How Long to Wait Before Changing Antipsychotics in Schizophrenia?

October 1, 2024
Lara Tang, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Lara Tang, MD. Dr. Tang has no financial relationships with companies related to this material.

How long should you wait before making changes after initiating an antipsychotic? The current study tested if early efficacy on an antipsychotic predicts subsequent efficacy, and its findings indicate benefits may be observed as quickly as two weeks. 


Read More
Research Update

Antipsychotic Dosing: Differences Between Bipolar Mania and Schizophrenia

August 1, 2024
Kate J. Travis, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Conventional wisdom suggests that antipsychotics need similar doses for mania and schizophrenia. This analysis clarifies the exceptions.


Read More
Expert Q&A

Treatment Challenges in Atypical Parkinsonism

July 1, 2024
Alice Flaherty, MD, PhD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CGPR_QA1_Alice-Flaherty_photo.jpgAlice Flaherty, MD, PhD. 

Neurologist, Massachusetts General Hospital; associate professor of neurology and psychiatry, Harvard Medical School, Cambridge, MA.

Dr. Flaherty has no financial relationships with companies related to this material.

Patients with atypical parkinsonism are less responsive to levodopa, and psychiatric medications can exacerbate motor symptoms. Dr. Flaherty advises how to choose the right treatment in patients with parkinsonism accompanied by psychosis, apathy, anxiety, and depression.


Read More
Research Update

Antipsychotic Polypharmacy: Maybe Not So Risky After All?

July 1, 2024
Sébastien Hardy, PharmD, BCPS
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sébastien Hardy, MD. Dr. Hardy has no financial relationships with companies related to this material.

The findings of this large study offer some reassurance about the safety and efficacy of antipsychotic polypharmacy, despite general treatment guidelines cautioning against it.



Read More
Clinical Update

Don’t Delay: Interventions in Early Psychosis

July 1, 2024
Brian Holoyda, MD, MPH, MBA
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Brian Holoyda, MD. Chief Psychiatrist, Contra Costa County Detention Health Services, Martinez, CA. Dr. Holoyda has no financial relationships with companies related to this material.

We highlight the profound difference early intervention makes in the trajectory of psychotic disorders, reducing symptom severity, suicide risk, and functional impairment.


Read More
Research Update

Does Haloperidol Improve ­Hospitalization or Mortality in Delirium?

June 1, 2024
Jeremy Mills, DNP, PMHNP-BC
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Jeremy Mills, DNP, PMHNP-BC. Dr. Mills has no financial relationships with companies related to this material.

Another trial questions the benefits of antipsychotics in delirium.


Read More
Expert Q&A

Managing Behavioral and Psychological Disturbances in the Nursing Home

April 1, 2024
Maureen C. Nash, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CGPR_QA2_Maureen-Nash.jpgMaureen C. Nash, MD.

Medical Director, Providence ElderPlace PACE Oregon. Co-editor, Neurocognitive Behavioral Disorders: An Interdisciplinary Approach to Patient-Centered Care (Springer; 2019). All comments are Dr. Nash’s personal views and not those of any organization.

Dr. Nash has no financial relationships with companies related to this material.

Dr. Maureen Nash shares how CMS regulations for using antipsychotics in nursing homes affects quality of care.


Read More
More Articles Tagged with 'antipsychotics'
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2603816031.jpg
    General Psychiatry

    A Scam for Every Woman, Child, and Man: Part 2

    1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.